Dynavax Technologies Corporation (DVAX) earnings · rev $277.2M
These earnings events as JSON? API free 100/dayDynavax Technologies Corporation (DVAX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
This DVAX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported DVAX revenue for 2024-12-31 was $277.2M. Net income was $27.3M. Revenue was up 19.4% from 2023-12-31 to 2024-12-31. DVAX currently screens at market cap $1.82B.
When the next DVAX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 19.4% from 2023-12-31 to 2024-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full DVAX research stays on the stock page; the tape stays on the quote page.
DVAX earnings FAQ
What are DVAX's latest revenue and net income?
Latest cached Dynavax Technologies Corporation (DVAX) revenue for Dec 31, 2024 was $277.2M. Net income was $27.3M. Statements: https://lician.com/financials/dvax
What is DVAX's latest diluted EPS?
Latest cached Dynavax Technologies Corporation (DVAX) diluted EPS for Dec 31, 2024 was $0.20.
What period does the latest DVAX earnings print cover?
The latest cached Dynavax Technologies Corporation (DVAX) earnings print covers Dec 31, 2024. The prior cached period on this page is Dec 31, 2023.
How did DVAX revenue change from the prior cached period?
Cached Dynavax Technologies Corporation (DVAX) revenue was up 19.4% from $232.3M (Dec 31, 2023) to $277.2M (Dec 31, 2024). Statements: https://lician.com/financials/dvax
Where are DVAX earnings listed?
Cached earnings facts for Dynavax Technologies Corporation (DVAX) are listed at https://lician.com/earnings/dvax. Statements: https://lician.com/financials/dvax
Not investment advice.